Henry O. Gosebruch, Chief Strategy Officer at AbbVie Inc. (ABBV), sold 1,537 shares at $70.01 ($108K) on 2017-07-31, disclosed to the SEC on 2017-08-02.
Open-market sale of $108k ABBV by Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ABBV | SELL | 2022-05-20 | $13.0M | — | Filing → |
| ABBV | SELL | 2022-03-02 | $6.8M | — | Filing → |
| ABBV | SELL | 2022-03-01 | $2.2M | — | Filing → |